Related Experiment Video
Updated: Oct 15, 2025

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
Rethinking rare disease: longevity-enhancing drug targets through X-linked aneuploidy
1Relation Therapeutics, London, UK; Juvenescence Ltd., London, UK.
Abstract:
Complex diseases, including ageing, often exhibit sexual dimorphism. These sex differences can obfuscate attribution to causal genes within a target ID campaign. Mendelian randomisation (MR)-inspired analysis provides a natural setting to incorporate X-linked aneuploid populations, resulting in prioritisation of longevity-enhancing drug targets and motivating greater inclusion of said populations in future profiling studies.
Related Concept Videos
Nondisjunction
Targeted Cancer Therapies
There are several types of targeted therapies against...
Sex-linked Disorders
X-linked Traits
Inheritance of Chromatin Structures
Replicative Cell Senescence

